Mathieu Boulin
Inserm(FR)Inserm(FR)Université de Bourgogne(FR)CHU Dijon Bourgogne(FR)Centre Hospitalier Universitaire Dijon Bourgogne(FR)Maison des Sciences sociales et des Humanités de Dijon(FR)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Medication Adherence and Compliance, Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology, Cancer Mechanisms and Therapy
Most-Cited Works
- → Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma(2011)79 cited
- → Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of theIDASPHEREphase I trial(2014)60 cited
- → Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb(2020)57 cited
- → Clinical and economic impact of pharmacist interventions in an ambulatory hematology–oncology department(2020)45 cited
- → Impact of Lockdown on Patients with Congestive Heart Failure During the Coronavirus Disease 2019 Pandemic(2020)45 cited
- → Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin(2015)42 cited